These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 942368)

  • 1. [Results in the use of blood components separated by cytophoresis in leukemia treated with cytostatics (our 1st experiences with flowing-effect centrifuge)].
    Bosković S; Haracić M
    Bilt Hematol Transfuz; 1976; 4(1-2):97-104. PubMed ID: 942368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Our experiences in the treatment of acute leukemias].
    Jelić S; Dragović M; Vidaković B; Plecas V
    Bilt Hematol Transfuz; 1976; 4(1-2):87-95. PubMed ID: 1066129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation.
    Mueller MM; Seifried E
    Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of granulocyte concentrates from healthy donors using a continuous-flow centrifuge (CFC)].
    Grgicević D; Pistotnik M; Flego I
    Bilt Hematol Transfuz; 1976; 4(3):53-60. PubMed ID: 1008798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte depletion of cellular blood components.
    Lane TA
    Curr Opin Hematol; 1994 Nov; 1(6):443-51. PubMed ID: 9371321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Replacement therapy with blood components in bone-marrow depression due to cytostatic drugs (author's transl)].
    Höcker P; Pittermann E; Mann M; Krasa E
    Wien Klin Wochenschr; 1980 Aug; 92(15):530-5. PubMed ID: 7001766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Our experience with revision total knee arthroplasty].
    Musil D; Stehlík J; Stárek M
    Acta Chir Orthop Traumatol Cech; 2005; 72(1):6-15. PubMed ID: 15860146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Supportive therapy with blood components].
    Höcker P
    Wien Med Wochenschr; 1991; 141(9-10):209-12. PubMed ID: 1949846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Addiction and brief-systemic therapy: working with compulsion].
    Cottencin O; Doutrelugne Y; Goudemand M; Consoli SM
    Encephale; 2009 Jun; 35(3):214-9. PubMed ID: 19540406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modern treatment of leukemia and hematopoietic stem cell transplantation].
    Pejin D; Stefanović N; Belić A; Popović S; Spasojević J; Uzurov V; Savić I; Savić A
    Med Pregl; 1997; 50(11-12):473-9. PubMed ID: 9471506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.